Navigation Links
Soligenix Reports Third Quarter 2011 Financial Results
Date:11/14/2011

e recommendation of an independent Data Safety Monitoring Board.  While we continue to analyze the dataset from this trial, we remain committed to evaluating all strategic options to re-establish the value of Soligenix, including through the development of our oral BDP programs for pediatric Crohn's disease, acute radiation syndrome and acute radiation enteritis as well as through our vaccines/biodefense programs with our novel thermostability technology and ricin toxin vaccine. We look forward to making news in some of these areas in the not too distant future."

Soligenix's Third Quarter and Recent News:

  • On October 11, 2011, Soligenix announced the formation of a Medical Advisory Board (MAB) to provide medical/clinical strategic guidance related to the development of SGX203 (oral beclomethasone dipropionate, or oral BDP) for the treatment of pediatric Crohn's disease.
  • On September 15, 2011, Soligenix announced the recommendation of an independent Data Safety Monitoring Board to stop its confirmatory Phase 3 clinical trial for orBec® in the treatment of acute GI GVHD for futility.
  • On July 28, 2011, Soligenix announced the expansion and amendment of its North American licensing partnership with Sigma-Tau for the development and commercialization of orBec® (oral beclomethasone dipropionate or Oral BDP) into the European territory. As part of the amended agreement, Sigma-Tau made a $5 million payment to Soligenix. 

About Soligenix, Inc.

Soligenix is a development stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Soligenix's lead product, orBec® (oral beclomethasone dipropionate), is a potent, locally acting corticosteroid that has been initially developed for the treatment of acute
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Soligenix Announces Formation of Pediatric Crohns Disease Medical Advisory Board
2. Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD
3. Soligenix Reports Second Quarter 2011 Financial Results and Reviews Accomplishments
4. Soligenix Announces Expansion of Partnership With Sigma-Tau Pharmaceuticals for orBec® in Europe
5. Soligenix Announces Appointment of Jerome Zeldis, MD, PhD and Keith Brownlie, CPA to its Board of Directors
6. Soligenix Appoints Joseph Warusz as Vice President of Administration and Controller
7. Soligenix to Present at 13th Annual BIO CEO & Investor Conference
8. Soligenix Appoints Kevin Horgan, MD, as Chief Medical Officer
9. Soligenix Executes Exclusive License with the University of Colorado for Vaccine Thermostabilization Technology
10. Soligenix Announces Positive Preliminary Results of SGX202 in Radiation Injury
11. Soligenix Announces Preliminary Results of its Phase 2 Clinical Trial of orBec® in the Prevention of Acute GVHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Mass. , Sept. 18, 2014  Spring ... novel therapeutics for the treatment of RNA viruses, ... Institutes of Health (NIH) for animal testing of ... viral pathogens, classified as "Special Pathogens," against which ... 9200, derived from Spring Bank,s proprietary ...
(Date:9/18/2014)... 18, 2014  RXi Pharmaceuticals Corporation (NASDAQ: ... focused on discovering, developing and commercializing innovative ... RNA-targeted technologies, today announced that the Company,s President ... Cauwenbergh , will present at the 7 ... Wednesday, September 24, 2014 at 11:20 a.m. ...
(Date:9/17/2014)... DALLAS , Sept. 17, 2014 /PRNewswire-iReach/ -- ... Methyl Methacrylate (MMA) Industry" and "2014 Market Research ... research reports to its store. Photo ... Market Research Report on Global Methyl Methacrylate (MMA) ... on China and Global ...
Breaking Medicine Technology:Spring Bank Pharmaceuticals Announces NIH Collaboration for Testing of SB 9200 Against Multiple Viral Pathogens 2RXi Pharmaceuticals to Present at the 7th Annual BioPharm America Conference 2RXi Pharmaceuticals to Present at the 7th Annual BioPharm America Conference 3Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 2Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 3Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 4Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 5
(Date:9/18/2014)... 18, 2014 -- Only about half of all pregnant ... leaving thousands of moms-to-be and their babies at increased risk ... should be a routine part of prenatal care," said Edward ... providers should offer their pregnant patients a flu shot each ... it." , A report by the U.S. Centers for Disease ...
(Date:9/18/2014)... German . In ... fight a pathogen tooth and nail, but rather tolerate it to ... of tolerance is that the disease only progresses very slowly ... pathogen load. , Roland Regoes, a senior scientist at ETH Zurich,s ... He set about investigating whether there are infected people who are ...
(Date:9/18/2014)... CRDF Global released today its ... edition – rich with videos, images and interactive ... Global empowers scientists and innovators around the world. ... foundation and individual supporters, CRDF Global reaches across ... training and entrepreneurship. , The Annual Report highlights ...
(Date:9/18/2014)... Africa (PRWEB) September 18, 2014 Phela ... adopt the HABIT™ Program in South Africa. ... Health and Wellness, and distributed in South Africa by ... the HABIT program, which has been tailored to address ... HABIT™ focuses on behavior modification and chronic disease prevention. ...
(Date:9/18/2014)... new expert panel report, Improving Medicines for Children ... Canadian Academies, addresses the importance of developing safe ... half of Canada,s seven million children use at ... is done off-label (i.e. the prescription differs from ... have historically been excluded in drug research and ...
Breaking Medicine News(10 mins):Health News:Flu vaccine for expectant moms a top priority 2Health News:Withdrawal from the evolutionary race 2Health News:Withdrawal from the evolutionary race 3Health News:CRDF Global Launches Media-Rich Digital Edition of Annual Report, Tells Story of Empowering Scientists and Innovators around the World in 2013 2Health News:Improving medicines for children in Canada 2
... Event at Penn State Hershey to Launch 2008 ... Thousands of,Pennsylvania taxpayers who participate in the ... Research deserve recognition for the,thousands of dollars in ... year. On Monday, February 11 at 9:30 a.m., ...
... Montreal, 6 February 2008 - A recent study by ... Health Centre research Institute, sheds some new light on ... Hastons study is pointing at genetics as contributing to ... implications in changing therapeutic practices. The article was published ...
... ) announced today that its Chief Executive Officer, Mark,McAndrew, and Chief Financial Officer, ... Conference in,New York City. Torchmark,s presentation is scheduled to begin at 2:20 p.m.,EST., ... The presentation will be webcast live at:, ... http://www.torchmarkcorp.com ...
... Group on,Health (NBGH) and the Office of Minority Health ... 2008 at 1:30 p.m. EST to announce a new,initiative ... improve the quality of health care for a culturally ... and public health,together to develop guidance and strategies for ...
... Tobacco-Free Kids, WASHINGTON, Feb. 7 The World ... clear both,the devastating scope of the global tobacco epidemic ... the world today - and the fact that it ... presents the first comprehensive picture of what the world,s ...
... February 19, 9 a.m. - 5 p.m.), SCOTTSDALE, ... Children,s Dental Health Month. Dr. Lee Weinstein, a ... Associates for Kids Only, will be offering a Free ... a.m. until 5 p.m., The first 30 patients that ...
Cached Medicine News:Health News:The Pennsylvania Breast Cancer Coalition Announces 2008 Breast Cancer Income Tax Check-Off Grant Recipients 2Health News:Landmark WHO Report on Global Tobacco Epidemic Should Spur Urgent Action by Nations to Implement Proven Solutions 2Health News:Landmark WHO Report on Global Tobacco Epidemic Should Spur Urgent Action by Nations to Implement Proven Solutions 3Health News:Free Children's Dental Day; Expert Source on Children's Dental Health Available 2
Straight shafts with 0.5 mm teeth and 6 mm tying platform. Wide serrated handle with thumb catch lock and polished finish....
Straight shafts with 0.12 mm teeth and tying platform. Serrated handle with polished finish....
Heavy curved shafts with 2 x 2 teeth and crisscross serrated 6 mm tying platform. Serrated handle with polished finish....
Straight shafts with 5.5 mm tying platform. 0.3 mm gap at platform heel. True round knurled handle in the closed position. Polished finish. Tips: 0.12 mm teeth....
Medicine Products: